Full CoverageFDA announces voucher program to speed drug reviews
By Chris Dall
Top news
FDA to offer faster drug reviews to companies promoting ‘national priorities’
By Matthew Perrone
FDA launches new priority review voucher program for biopharmas that 'align with national priorities'
By Gabrielle Masson
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI
By Liz Essley Whyte
Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews
By Annika Kim Constantino & Ashley Capoot
All coverage
FDA announces sweeping changes to Drug Review process
By Kristine Frazao
US FDA to shorten review time for drug developers under new voucher program
By Shinjini Ganguli
Makary Calls for “New FDA” at BIO; Defends Agency’s Spring Job Cuts
By Alex Philippidis
Will FDA’s New Review Process Sell Drug Approvals to the Highest Bidder?
By Crystal Lindell
FDA Offers Rapid Review Voucher Program for Drugmakers 'Supporting US National Interests'
By Alexandra Byrne
Makary’s priority pathway charts new territory, linking regulatory decisions to national security
By Steven T. Usdin
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
By Annalee Armstrong
FDA voucher program expedites high-need drug approvals
By Alivia Kaylor
FDA's Makary talks up modernizing agency to get drugs to market faster
By Jonathan Block, MPH
FDA to speed reviews for drugs supporting ‘national interests’
By Jonathan Gardner
FDA Announces New Vouchers to Cut Drug Reviews to Two Months
By Michelle Amponsah
National Priority Voucher Gives US FDA Commissioner Tool For Radical Regulatory Surgery
By Bridget Silverman
FDA Commissioner Launches Pilot Program To Speed Review of Certain Drugs
By Rachel S Turow & Maya Florence
FDA's new speedy review programme will be open only to US drugmakers
By Elizabeth Eaton
FDA announces a new priority review program in bid to further administration goals | STAT
By Lizzy Lawrence